Citation: P. Roach et al., Improved glycaemic control with the use of self-prepared mixtures of insulin lispro and insulin lispro protamine suspension in patients with types 1 and 2 diabetes, INT J CL PR, 55(3), 2001, pp. 177-182
Authors:
Roach, P
Koledova, E
Metcalfe, S
Hultman, C
Milicevic, ZO
Citation: P. Roach et al., Glycemic control with Humalog (R) Mix25 (TM) in type 2 diabetes inadequately controlled with glyburide, CLIN THER, 23(10), 2001, pp. 1732-1744
Authors:
Hernandez, H
Hewitson, KS
Roach, P
Shaw, NM
Baldwin, JE
Robinson, CV
Citation: H. Hernandez et al., Observation of the iron-sulfur cluster in Escherichia coli biotin synthaseby nanoflow electrospray mass spectrometry, ANALYT CHEM, 73(17), 2001, pp. 4154-4161
Authors:
Matlow, AG
Harrison, A
Monteath, A
Roach, P
Balfe, JW
Citation: Ag. Matlow et al., Nosocomial transmission of tuberculosis (TB) associated with care of an infant with peritoneal TB, INFECT CONT, 21(3), 2000, pp. 222-223
Authors:
Abbey, M
Owen, A
Suzakawa, M
Roach, P
Nestel, PJ
Citation: M. Abbey et al., Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity, MATURITAS, 33(3), 1999, pp. 259-269
Citation: P. Roach et al., Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation, DIABET CARE, 22(8), 1999, pp. 1258-1261
Authors:
Roach, P
Trautmann, M
Arora, V
Sun, B
Anderson, JH
Citation: P. Roach et al., Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro-protamine formulations,insulin lispro Mix25 and insulin lispro Mix50, CLIN THER, 21(3), 1999, pp. 523-534